SynthesisCardiovascular diabetology2021

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review.

Chen-Yi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.